Radiotherapy Treatments for Neoplasms of the Limbs

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorEuropean Institute of Oncology

About this trial

In this observational study patients treated at European Institute of Oncology with radiotherapy to limbs will be included

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Signed informed consent

Disqualifiers

None

Trial population

Patients treated at European Institute of Oncology with radiotherapy to limbs

Trial design

Design model

Case-only

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

3,000 Participants
are grouped into 1 trial group
Group A: Radiotherapy to limbs

Trial outcomes

Primary outcomes

1

Overall survival

Number of patients death

Time frame
5 years
2

Disease free survival

Number of oncological event (local recurrence, distant metastasis, other primary tumor)

Time frame
5 years

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.